Literature DB >> 170501

Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.

R J Haslam, G M Rosson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 170501

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN： 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  38 in total

1.  Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.

Authors:  H S Park; S M Hourani
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Deconstructing tick saliva: non-protein molecules with potent immunomodulatory properties.

Authors:  Carlo José F Oliveira; Anderson Sá-Nunes; Ivo M B Francischetti; Vanessa Carregaro; Elen Anatriello; João S Silva; Isabel K F de Miranda Santos; José M C Ribeiro; Beatriz R Ferreira
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

3.  Immunological identification of A2 adenosine receptors by two antipeptide antibody preparations.

Authors:  T M Palmer; K A Jacobson; G L Stiles
Journal:  Mol Pharmacol       Date:  1992-09       Impact factor: 4.436

Review 4.  Regulation of adenylate cyclase by adenosine.

Authors:  J N Fain; C C Malbon
Journal:  Mol Cell Biochem       Date:  1979-06-15       Impact factor: 3.396

5.  Binding of dipyridamole to human platelets and to alpha1 acid glycoprotein and its significance for the inhibition of adenosine uptake.

Authors:  K Subbarao; B Rucinski; M A Rausch; K Schmid; S Niewiarowski
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

6.  Effects of adenosine derivatives on cAMP accumulation and lipolysis in rat adipocytes and on adenylate cyclase in adipocyte plasma membranes.

Authors:  T Trost; K Stock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-08       Impact factor: 3.000

7.  Adenosine-induced release of cyclic adenosine 3',5'-monophosphate from the left ventricle in the anaesthetized intact dog.

Authors:  T Huynh-Thu; J Lammerant
Journal:  J Physiol       Date:  1978-06       Impact factor: 5.182

8.  Inhibition of platelet aggregation by adenosine receptor agonists.

Authors:  G Cristalli; S Vittori; R D Thompson; W L Padgett; D Shi; J W Daly; R A Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

9.  Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.

Authors:  E Hüttemann; D Ukena; V Lenschow; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

10.  13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Authors:  G C Le Breton; D L Venton; S E Enke; P V Halushka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.